The rising uncertainty about a healthcare system under President Trump is starting to sink in and the market seems to be in sell mode for pharmaceutical companies. So it’s a good time to sell Opko Health (NSDQ: OPK), a company specializing in hormone treatments and kidney dialysis related treatments, with a 10-plus percent gain while we still can. We bought the stock at $8 in February 2016 and although it has made some progress, it has been churning around $9 for several months despite steady buying by the company CEO and aggressive expansion through acquisition. 

Sell Opko Health Inc. (OPK) Bought on 2/1/16 at $8. Closing Price on 11/4/16 was $9.78.

Dr. Duarte owns shares in OPK.